The MarketWatch News Department was not involved in the creation of this content. TriNetX(R) will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase(R) ...
Regeneron (REGN) has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data Collaboration will ...
Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to ...
TARRYTOWN, N.Y. and CAMBRIDGE, Mass. - Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced today a collaboration with TriNetX to access de-identified electronic health record data from ...
TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation CAMBRIDGE, Mass. and CAMBRIDGE, United ...
Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX's industry-leading global network of electronic health record data Collaboration will expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results